Clenbuterol toxicity: a NSW Poisons Information Centre experience
暂无分享,去创建一个
[1] H. Spiller,et al. A Descriptive Study of Adverse Events from Clenbuterol Misuse and Abuse for Weight Loss and Bodybuilding , 2013, Substance abuse.
[2] M. Malesker,et al. Human health hazards of veterinary medications: information for emergency departments. , 2011, The Journal of emergency medicine.
[3] V. Mabasa,et al. Acute clenbuterol overdose resulting in supraventricular tachycardia and atrial fibrillation , 2007, Journal of Medical Toxicology.
[4] R. Hoffman,et al. A descriptive study of an outbreak of clenbuterol-containing heroin. , 2008, Annals of emergency medicine.
[5] R. Hoffman,et al. Pulmonary edema and respiratory failure associated with clenbuterol exposure. , 2007, The American journal of emergency medicine.
[6] J. Kasprzak,et al. Myocardial infarction in a 17-year-old body builder using clenbuterol. , 2005, Circulation journal : official journal of the Japanese Circulation Society.
[7] F. Ramos,et al. Food poisoning by clenbuterol in Portugal , 2005, Food additives and contaminants.
[8] T Y Chan,et al. Health hazards due to clenbuterol residues in food. , 1999, Journal of toxicology. Clinical toxicology.
[9] V. Plumb,et al. Clenbuterol and anabolic steroids: a previously unreported cause of myocardial infarction with normal coronary arteriograms. , 1998, Southern medical journal.
[10] G A Mitchell,et al. Illegal use of beta-adrenergic agonists in the United States. , 1998, Journal of animal science.
[11] H. Kuiper,et al. Illegal use of beta-adrenergic agonists: European Community. , 1998, Journal of animal science.
[12] P. Salvà,et al. Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain. , 1995, Public health reports.
[13] B. Reigner,et al. Steady-state bioavailability and pharmacokinetics of ambroxol and clenbuterol administered alone and combined in a new oral formulation. , 1989, International journal of clinical pharmacology, therapy, and toxicology.